VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DRUG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DRUGBright Minds Biosciences Inc.
$69.18$537M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDRUGQuarterly Financials

Bright Minds Biosciences Inc. (DRUG) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Bright Minds Biosciences Inc. (DRUG) quarterly income statement — complete revenue, gross profit & net income history

DRUG Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold20.13K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-20.13K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses15.55M6.9M5.66M3.3M3.35M1.62M791.31K-234.74K558.06K1.7M1.55M1.43M2.05M2.3M3.01M2.66M4.48M4.82M2.97M3.65M
OpEx % of Revenue--------------------
Selling, General & Admin2.28M1.09M756.4K591.94K676.16K540.93K351.01K320.64K363.6K401.18K459.16K380.32K562.64K797.69K430.86K603.28K640.58K876.35K744.99K887.05K
SG&A % of Revenue--------------------
Research & Development13.27M5.66M4.78M2.69M2.56M1.05M416.06K-566.75K105.18K1.23M1.09M1.05M1.4M1.46M2.54M2.05M3.74M3.85M2.21M2.71M
R&D % of Revenue--------------------
Other Operating Expenses0154.22K123.93K12.52K112.84K38.35K24.24K11.36K89.29K72.29K0093.09K40.92K39.12K8.01K93.51K102.44K13.5K52.33K
Operating Income-15.57M-6.9M-5.66M-3.3M-3.35M-1.62M-791.31K234.74K-558.06K-1.7M-1.55M-1.43M-2.05M-2.3M-3.01M-2.66M-4.48M-4.82M-2.97M-3.65M
Operating Margin %--------------------
Operating Income Growth %-364.46%-324.96%-615.84%-1504.23%-500.66%4.38%48.96%116.4%72.83%26.08%48.51%46.26%54.12%52.36%-1.5%27%-187.96%-681.56%-647.16%-
EBITDA-15.55M-6.88M-5.65M-3.28M-3.33M-1.6M-772.29K252.85K-539.95K-1.68M00-2.04M-2.28M-3.01M-2.66M-4.48M-4.82M-2.97M-3.65M
EBITDA Margin %--------------------
EBITDA Growth %-366.99%-329.43%-631.27%-1397.37%-516.65%4.63%--73.48%26.28%100%100%54.53%52.73%-1.5%27%-187.96%-681.56%-647.16%-
D&A (Non-Cash Add-back)20.13K19.79K17.01K15.85K22.48K21.53K19.02K18.11K18.11K18.11K1.55M1.43M18.11K18.11K000000
EBIT-15.57M-6.9M-5.66M-3.3M-3.35M-1.62M-791.31K234.74K-558.06K-1.7M-1.55M-1.43M-2.05M-2.3M-3.01M-2.66M-4.48M-4.82M-2.97M-3.65M
Net Interest Income2.73M818.26K529.54K476.23K509.38K4.32K6.01K14.99K000000000000
Interest Income2.73M818.26K529.54K476.23K509.38K4.32K6.01K14.99K000000000000
Interest Expense5.59K0000000000000000000
Other Income/Expense4.94M-661.24K1.58M-1.95M401.7K1.67M17.87K-4.84K-16.08K14.73K22.48K-27.29K3.5K-37.13K50.17K4.27K-10.21K-34.09K99.63K114.06K
Pretax Income-10.63M-7.57M-4.09M-5.24M-2.95M49.61K-773.44K229.9K-574.14K-1.68M-1.53M-1.46M-2.05M-2.34M-2.96M-2.66M-4.49M-4.86M-2.87M-3.53M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-10.63M-7.57M-4.09M-5.24M-2.95M49.61K-773.44K229.9K-574.14K-1.68M-1.53M-1.46M-2.05M-2.34M-2.96M-2.66M-4.49M-4.86M-2.87M-3.53M
Net Margin %--------------------
Net Income Growth %-260.43%-15349.58%-428.24%-2380.51%-413.88%102.95%49.38%115.77%72%27.88%48.4%45.14%54.31%51.93%-3.28%24.77%-183.43%-617.52%-612.08%-
Net Income (Continuing)-10.63M-7.57M-4.09M-5.24M-2.95M49.61K-773.44K229.9K-574.14K-1.68M-1.53M-1.46M-2.05M-2.34M-2.96M-2.66M-4.49M-4.86M-2.87M-3.53M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.12-0.97-0.41-0.74-0.630.01-0.170.05-0.13-0.44-0.41-0.39-0.56-0.68-0.98-1.12-1.90-2.05-1.21-1.56
EPS Growth %-77.78%-9165.42%-141.18%-1701.73%-384.62%102.43%58.54%111.85%76.79%35.29%58.16%65.18%70.53%66.83%19.01%28.21%-66.67%-215.38%-266.67%-
EPS (Basic)-1.12-0.97-0.41-0.74-0.660.01-0.170.05-0.13-0.44-0.41-0.39-0.56-0.68-0.98-1.12-1.90-2.05-1.21-1.56
Diluted Shares Outstanding9.59M7.76M7.17M7.08M4.65M4.65M4.65M4.65M4.46M3.84M3.77M3.77M3.79M3.59M2.98M2.37M2.37M2.37M2.37M2.26M
Basic Shares Outstanding9.59M7.76M7.17M7.08M4.46M4.46M4.46M4.46M4.46M3.84M3.77M3.77M3.79M3.59M2.98M2.37M2.37M2.37M2.37M2.26M
Dividend Payout Ratio--------------------